Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives: Evidence for a Change in Paradigm

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a heritable myocardial disease with age-related penetrance. Current guidelines recommend clinical screening of relatives beginning at 10 years of age, but the clinical value of this approach has not been systematically evaluated. METHODS: Anonymized c...

Descripción completa

Detalles Bibliográficos
Autores principales: Norrish, Gabrielle, Jager, Joanna, Field, Ella, Quinn, Ellie, Fell, Hannah, Lord, Emma, Cicerchia, Marcos N., Ochoa, Juan Pablo, Cervi, Elena, Elliott, Perry M., Kaski, Juan Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636798/
https://www.ncbi.nlm.nih.gov/pubmed/31006259
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636798/
https://www.ncbi.nlm.nih.gov/pubmed/31006259
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038846

Ejemplares similares